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ABSTRACT
Nonhomologous end-joining (NHEJ) is an important
pathway for the repair of DNA double-strand breaks
(DSBs) and plays a critical role in maintaining geno-
mic stability in mammalian cells. While Ku70/80 (Ku)
functions in NHEJ as part of the DNA-dependent
protein kinase (DNA-PK), genetic evidence indicates
that the role of Ku in NHEJ goes beyond its partici-
pation in DNA-PK. Inositol hexakisphosphate (IP6)
was previously found to stimulate NHEJ in vitro
and Ku was identified as an IP6-binding factor.
Through mutational analysis, we identified a bipar-
tite IP6-binding site in Ku and generated IP6-binding
mutants that ranged from 1.22% to 58.48% of wild-
type binding. Significantly, these Ku IP6-binding
mutants were impaired for participation in NHEJ
in vitro and we observed a positive correlation
between IP6 binding and NHEJ. Ku IP6-binding
mutants were separation-of-function mutants that
bound DNA and activated DNA-PK as well as
wild-type Ku. Our observations identify a hitherto
undefined IP6-binding site in Ku and show that this
interaction is important for DSB repair by NHEJ
in vitro. Moreover, these data indicate that in addi-
tion to binding of exposed DNA termini and activa-
tion of DNA-PK, the Ku heterodimer plays a role in
mammalian NHEJ that is regulated by binding of IP6.
INTRODUCTION
Double-strand breaks (DSBs) in DNA represent a signiﬁ-
cant threat to viability and genomic integrity in all cells. In
multicellular organisms, genomic instability arising from a
DSB can lead to tumorigenesis, which makes the mecha-
nisms of DSB repair of considerable interest. In late S or
G2 phases of the cell cycle, DSBs can be repaired by
homologous recombination. In G1 or early S phases of
the cell cycle, the lack of sister chromatids dictates the
use of the homology-independent DSB repair mechanism
nonhomologous end-joining (NHEJ) (1). This is also the
case for the terminally diﬀerentiated (G0) cells that con-
stitute the majority of cells in multicellular organisms and
makes NHEJ the more widely used DSB repair mecha-
nism in humans (1). In addition to repair of spontaneous
DSBs, NHEJ is also used to repair programmed DSBs
that arise during rearrangement of the immunoglobulin
loci through the processes of V(D)J and class switch
recombination. Failure to repair these programed DSBs
results in a lack of immunoglobulin production, and inap-
propriate repair of these unique DSBs has been linked to
the establishment of lymphomas (2).
Genetic and biochemical analysis have identiﬁed several
factors required for mammalian NHEJ. DNA ligase IV is
directly responsible for restoration of the phosphodiester
bond at the site of the DSB and forms a complex with the
XRCC4 protein, which is required for ligase IV stability
and is therefore required for NHEJ (1,2). XLF, also
known as Cernunnos, is thought to bind XRCC4 to
form a ligase IV/XRCC4/XLF complex, which is essential
for NHEJ (3,4). Additionally, the Artemis nuclease has
been shown to participate in this pathway and is thought
to be required for processing of nonligatable ends (5).
The heterotrimeric DNA-dependent protein kinase
(DNA-PK) is also required for NHEJ in mammals (6,7).
Composed of the DNA-PK catalytic subunit (DNA-
PKcs), a PI3K-related protein kinase, and the Ku70/80
heterodimer (Ku), this large protein complex assembles
on exposed DNA termini to become an active protein
kinase that is, in general, unique to vertebrates (6). Ku
is composed of one 70kDa (Ku70) subunit and one
86kDa (Ku80) subunit. Heterodimerization of the Ku70
and Ku80 polypeptides results in a ring-shaped structure
that can thread onto an exposed DNA end with both
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DNA (8). This bipartite DNA-binding site, which is split
between the Ku70 and Ku80 subunits, provides a molecu-
lar mechanism for the required heterodimerization and the
observed structure-speciﬁc DNA end-binding activity of
Ku (8). Interestingly, while Ku and DNA-PKcs are both
required for DNA-PK activity, genetic experiments car-
ried out in mice show that Ku and DNA-PKcs do not
contribute equally to mammalian NHEJ. This is particu-
larly evident in the formation of signal and coding joints
during V(D)J recombination. DNA-PKcs deﬁciency in
mice results in the inability to produce coding joints,
while the ability to form signal joints is retained (6,7). In
contrast, Ku-deﬁcient mice fail to form both signal and
coding joints (6,7). These observations indicate that the
role of Ku in mammalian NHEJ extends beyond partici-
pation in DNA-PK.
We have shown that, in addition to activating DNA-
PKcs, Ku binds the small, phosphate-rich molecule inosi-
tol hexakisphosphate (IP6, Figure 1A), which we pre-
viously identiﬁed as a stimulatory factor in mammalian
NHEJ (9,10). Subsequent publications demonstrated
that binding of IP6 by Ku did not change the ability of
Ku to bind DNA or to assemble with DNA-PKcs to form
DNA-PK (10,11). These data suggest that the role of IP6
in mammalian NHEJ is tied to functions of Ku that are
independent of DNA-PK. To determine if binding of IP6
by Ku contributes to eﬃcient NHEJ, we used mutational
analysis to identify an IP6-binding site in Ku. This muta-
tional analysis revealed that the Ku IP6-binding site, like
its DNA-binding site, is bipartite and requires residues
from both Ku70 and Ku80 subunits. IP6-binding mutants
of Ku were separation-of-function mutants that stimu-
lated DNA-PK but showed reduced aﬃnity for IP6.
These separation-of-function mutants were also impaired
for complementation of NHEJ in Ku-depleted extracts,
which demonstrates that formation of a Ku–IP6 complex
is important for eﬃcient NHEJ in vitro. These data show
that the role of Ku in mammalian NHEJ may be divided
into DNA-PKcs-dependent and IP6-dependent functions.
MATERIALS AND METHODS
Cloning and mutagenesis
Ku70 entry vector (pENTKu70) was created as follows:
the human Ku70 cDNA (gift from S. West) was ampli-
ﬁed using primers Ku70.N and Ku70.C and cloned into
pCR 8/GW/TOPO (Invitrogen, Carlsbad, California).
Ku80 entry vector (pREh6Ku80) was created as follows: a
Figure 1. IP6 is required for NHEJ in vitro.( A) Structure of IP6. With D-myo-inositol as its base ring structure, IP6 has one axial phosphate group
(C-2), ﬁve phosphate groups in equatorial position and a molecular weight of 660 Da. (B) End-joining assays were carried out using 20mg of HeLa
WCE or AS65 as described in Materials and Methods section and complemented with IP6 or IS6. Treatment with Wortmannin (3mM, lanes 4 and 10)
and anti-XRCC4 antibodies ( -XRCC4, 1:250 dilution, lanes 3 and 9) demonstrate that the observed end joining is bona ﬁde NHEJ. A  ve sign
indicates no protein. Monomer, monomeric DNA substrate; dimer, trimer, etc., end-joined concatamers. (C)I P 6 increased the rate of NHEJ in vitro.
AS65 (20mg) was assayed for end joining as described in Materials and Methods section in the presence (left) or absence (right) of 1mMI P 6 for the
indicated time. (D) Quantiﬁcation of C presented as percent of ends joined as a function of reaction time. Graph includes controls in which reactions
were treated with anti-XRCC4 antibodies (1:250 dilution) to inhibit NHEJ (ﬁlled triangle,+IP6+a-XRCC4; open triangle,   IP6+a-XRCC4),
which are not shown in (C).
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ﬁve amino acids (gift from M. Lieber), was ampliﬁed
using primers attB4Ku80N and attB1Ku80C, BP-recom-
bined into pDONR
TM221 (Invitrogen) and the missing N-
terminal ﬁve amino acids were replaced by site-directed
mutagenesis (QuikChange II, Stratagene, La Jolla, CA)
using N5Ku80s and its complement. Sequences for oligo-
nucleotides used in cloning are provided in Supplementary
Table 1. In pENTKu70 and pREh6Ku80, lysine (K) resi-
dues were changed to alanines (A) by site-directed muta-
genesis (QuikChange II, Stratagene) using
oligonucleotides summarized in Supplementary Table 2.
All sequences were conﬁrmed by direct sequence analysis.
Wild-type and K-to-A mutant cDNAs were LR-recom-
bined into pDEST8 (Invitrogen) to create pBacuKu70,
pBacuKu70DM, pBacuKu80, pBacuKu80DM and
pBacuKu80TM.
Protein expression and purification
Baculoviruses were produced (BEVS, Invitrogen) and Sf-
21 cells were coinfected at 10
6 cells/ml with Ku70 virus
[Multiplicity Of Infection (M.O.I.)=10] and h6Ku80
virus (M.O.I.=5) for 4 days. Puriﬁcation was essentially
as previously described (12). Brieﬂy, cells were harvested
by centrifugation (1000g, 15min, 48C), stored at  808C
then resuspended in 30ml T Buﬀer (50mM Tris pH 7.5,
0.4M NH4OAc, 0.3MNaCl, 10% glycerol, 2mM b-mer-
captoethanol) with 0.2% NP-40 and 20mM imidazole per
1l original culture, lysed by homogenization (30 strokes,
loose pestle) and PMSF was added to a ﬁnal concentra-
tion of 1mM. We determined that the high salt concentra-
tion of T Buﬀer was suﬃcient to remove >99% of
prebound
3H-IP6 (data not shown). The resulting lysate
was sonicated (8 15s burst) and cellular debris was
removed by centrifugation (10000g, 10min, 48C).
Binding to Talon (Clontech, Mountain View, CA) metal
aﬃnity resin was carried out in batch (1h, 48C), washed in
batch with T Buﬀer, packed into a column and eluted T
Buﬀer with 0.5M imidazole. Eluted proteins were dialyzed
into HepQ Buﬀer (50mM Tris pH 7.5, 5% glycerol, 1mM
DTT and 1mM sodium metabisulphite) with 50mM
NaCl, loaded onto a 5ml Hi-trap heparin column
(GE, USA) and eluted with a 50mM to 1M NaCl linear
gradient in HepQ Buﬀer. Peak fractions were pooled, dia-
lyzed against HepQ Buﬀer with 50mMNaCl, loaded onto
a 1ml hi-trap Q column (GE) and eluted with a 50mM to
1MNaCl linear gradient in HepQ Buﬀer. Peak fractions
were pooled, dialyzed against HepQ Buﬀer with 50mM
NaCl and 10% glycerol (4h, 48C), snap-frozen and stored
at –808C. Ku wild-type protein concentration was deter-
mined by A280 measurement. Ku mutant protein concen-
tration was determined by Bradford assays using Ku wild-
type as the protein standard.
Electrophoretic mobility shiftassay
For examination of DNA binding by one Ku protein (8),
50 GTTTTTAGTTTATTGGGCGCG 30 was radiola-
beled, annealed to 50 CGCGCCCAGCTTTCCCAGCTA
ATAAACTAAAAAC 30 and gel puriﬁed. For examina-
tion of 1 and 2 Ku proteins bound to one double-stranded
DNA (dsDNA), 50 CTGAGAAAACTGTGCGTCTTCG
CGGCAATTGAGAGGCATTCCATTCAC 30 was radio-
labeled, annealed to 50 GTGAATGGAATGCCTCT
CAATTGCCGCGAAGACGCACAGTTTTCTCAG 30
and gel puriﬁed. Electrophoretic mobility shift assay
(EMSA) was done essentially as previously described
(12). Brieﬂy, binding to duplex DNA was carried out in
10ml reactions containing 50mM Tris, pH 7.75,
100mMKCl, 1mM DTT, 5% glycerol, 100mg/ml bovine
serum albumin, 5 nM
32P-labeled duplex DNA and
recombinant Ku as stated for 30min at room temperature.
Complexes were resolved on 5% (29:1 acrylamide:bis)
native PAGE in 0.5 TBE at 2.5V/min at room tempera-
ture. The gel was dried and subject to autoradiography.
Unlabeled 1.8kb dsDNA PCR fragment was used as
dsDNA competitor. Unlabeled single-stranded DNA
(ssDNA) competitor was 50 GAAACAATAGGAAAG
AAGTTTGAGGCGAGGCATATTGAAATATTCACT
GA 30. Quantiﬁcation of EMSA: images were captured on
a FLA-7000 Image Reader, processed using Multi Gauge
V3.0 software (Fuji Film) as percentage of DNA bound by
Ku=Bshifted/(Bshifted+Bfree DNA), where B=band
intensity.
DNA-PK assay
Ku-free DNA-PKcs was prepared from HeLa whole-cell
extract (WCE) as follows: HeLa nuclear extract was pre-
pared as previously described (13) and dialyzed against
J Buﬀer (25mM HEPES, pH 7.6, 2mMMgCl2, 0.5mM
EDTA, 20% glycerol, 1mM DTT, 1mM sodium metabi-
sulphite and 0.2mM PMSF) with 50mM KCl. The extract
was fractionated over the following columns: Q-sepharose
Fast-ﬂow (GE), on SP-sepharose Fast-ﬂow (GE), Hi-Trap
Heparin (GE) and dsDNA cellulose (Sigma, Montana,
USA); all columns were run in J buﬀer and eluted with
a 50mM to 1M linear KCl gradient. Following fractiona-
tion over dsDNA cellulose DNA-PK-containing fractions
were pooled and the salt concentration adjusted to 0.6M
ammonium sulphate and fractionated on a Hi-Trap
phenyl sepharose column (GE) with a linear gradient of
0.5–0M ammonium sulphate in J Buﬀer with 50mM KCl.
Ku was detected by western blot analysis and found to be
in the column ﬂow through and 0.6M ammonium sul-
phate wash fractions. Fractions containing DNA-PKcs,
and lacking detectable Ku by western blot analysis, were
pooled and dialyzed into J Buﬀer with 0.1M KCl. DNA-
PK was assayed using the SIGNAtect DNA-PK assay
system (Promega, Madison, WI) according to manufac-
turer’s speciﬁcations. A total of 0.463 pmol of partially
puriﬁed DNA-PKcs was used in each kinase reaction.
IP6filter bindingassay
3H-IP6 was purchased from Perkin Elmer, Waltham,
Massachusett (custom order). Analytical strong anion
exchange (SAX) HPLC was used to determine that 80%
of
3H counts were contained in
3H-IP6 and overall purity
was 50%
3H-IP6. Attempts at preparative puriﬁcation by
SAX-HPLC were unsuccessful due to low speciﬁc activity
and concentration of the
3H-IP6. Ku–
3H-IP6 binding
reactions (15ml) were carried out in 20mM HEPES
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40mM KOAc, 10mM DTT with 10mM KPO4 pH 7.6
to provide an excess of phosphate to minimize nonspeciﬁc
binding of
3H-IP6. The 46.3 nM
3H-IP6 and 500 nM Ku
were found to produce maximum signal with minimum
background. Reactions were incubated for 60min.
Nitrocellulose ﬁlter paper (Schleicher and Schuell, USA,
BA85) was equilibrated with 20mM HEPES pH 7.6,
0.5mM EDTA, 10% glycerol, 10mM KPO4 pH 8.0,
and 1.5mM IP6 after which the binding reaction was
applied to the ﬁlter. Filters were washed 3 with 20mM
HEPES, pH 7.6, 0.5mM EDTA, 0.3M NaCl then dried
and
3H-IP6 was detected by scintillation counting. We
determined that 100% of the Ku remained bound to the
ﬁlter through this assay (data not shown). All solutions
and steps were at 48C. Competition assays (Figure 2A)
were done by combining
3H-IP6 and unlabeled IP6 or ino-
sitol hexasulphate (IS6) before adding Ku to the reaction.
Invitro NHEJ analysis
HeLa WCE was prepared as previously described (14). To
generate AS65, HeLa WCE before the ﬁnal dialysis was
subject to 65% ammonium sulphate precipitation and dia-
lyzed against L Buﬀer (20mM Tris pH 8.0, 0.1M KOAc,
10% glycerol, 0.5mM EDTA and 1mM DTT) for 2–4h.
In vitro NHEJ assays were carried out essentially as pre-
viously described (9,14). Brieﬂy, reactions (10ml) were
carried out in 50mM HEPES pH 8.0, 40mMKOAc,
0.5mM Mg(OAc)2, 1mM ATP, 1mM DTT, 0.1mg/ml
bovine serum albumin (BSA) and HindIII-linearized
50-
32P-labeled pBluescript DNA (10ng) with 20mgo f
WCE, AS65 or Ku-depleted AS65. The potassium concen-
tration was adjusted to 100mM by the addition of KOAc.
IP6 (Calbiochem, Gibbstown, NJ, USA) and IS6 (Sigma)
were added as indicated. In complementation assays using
Ku-depleted AS65, Ku was added at 180 nM. Neutralizing
anti-XRCC4 antibodies (Serotec, Raleigh, NC) and wort-
mannin (Sigma) were used as indicated with no preincuba-
tion. Reactions were incubated for 2h at 378C, stopped by
the addition of deproteinization solution (2ml, 10mg/ml
Proteinase K, 50mM EDTA, 0.1M Tris pH 7.5, 2.5%
SDS) and deproteinized for 30min at 378C. Products
were separated by agarose gel electrophoresis (0.6%,
TAE) and visualized by autoradiography. Quantiﬁcation
of end joining: images were captured on a FLA-7000
Image Reader, processed using Multi Gauge V3.0
software (Fuji Film) as percentage of ends join-
ed=
P
ðBÞðY=Y þ 1Þ=
P
ðBÞ
  
  100. B=Band intensity,
Y=number of ends joined for that species and Y+1is
the number of 3kb monomers in that band.
Ku-depleted extracts
Immunodepletions were carried out as previously
described (12) with modiﬁcations. Brieﬂy, monoclonal
anti-Ku antibodies were conjugated to protein A sephar-
ose beads (GE) overnight in NET-0.5 buﬀer (50mM Tris
pH 8.0, 0.15MNaCl, 1mM EDTA, 10% glycerol, and
0.5% NP-40) at 0.8mg anti-Ku antibodies per 1ml protein
A sepharose resin. AS65 was adjusted to a ﬁnal concen-
tration of 0.5M NaCl, added to the antibody-bound resin
(100mg AS65ml resin) and incubated with gentle mixing
(2h, 48C) after which the resin was removed by centrifu-
gation. Immunodepletion was repeated three times and
the Ku-depleted extract was dialyzed against L Buﬀer
for 4h and stored at  808C.
Antibodies
Antibodies directed against XRCC4, DNA-PKcs and
DNA Ligase IV (Serotec); Ku80 (Neomarkers); DNA
ligases I and III (GeneTex) were used for western blot
detection. Monoclonal anti-Ku70 (C-N3H10), anti-Ku80
(C-111) and anti-Ku70/80 (C-162) (Neomarkers) were
used to immunodeplete Ku with similar success.
Neutralizing anti-XRCC4 antiserum (Serotec) was used
in NHEJ assays.
RESULTS
IP6is requiredforefficient NHEJ in vitro
We have previously described the identiﬁcation of IP6 as a
stimulatory factor for mammalian NHEJ (9). These com-
plementation studies were carried out using a phosphocel-
lulose-bound (PC-C) fraction of human WCE (9).
Figure 2. Binding of IP6 by Ku. (A) Ku speciﬁcally binds to IP6, but not IS6. Filter binding assays were carried out as described in Materials and
Methods section using 46.3nM
3H-IP6 and 500nM Ku in the presence of increasing amounts of unlabeled IP6 or IS6. Retained
3H-IP6 binding was
measured as disintegration per minute (DPM). Values shown represent the mean of two independent experiments with each measurement made in
triplicate (N=2 and n=6). Error bars show standard error. (B) Identiﬁcation of a putative IP6-binding site in Ku. The Ku70/80 ribbon structure is
shown (PDB Accession No. 1JEY): Ku70 (red), Ku80 (yellow) and DNA (light gray). A cluster of conserved basic amino acids (blue space ﬁll) is
located near the Ku70/80 interface, away from the DNA-binding site and between the base of the Ku80N-terminal a/b domain and the Ku70 central
b-barrel domain. (C) Residues mutated in this study: 70DM—K357 K358 (pink space ﬁll); 80DM—K238 K239 (dark gray space ﬁll); and 80TM—
K233 K238 K239 (K233 black space ﬁll). Other basic amino acids that may be involved in Ku–IP6 interaction but were not examined in this study
are shown in blue. Bottom view of (B), which is rotated 908.( D) Expanded view of (C).
5716 Nucleic Acids Research, 2008, Vol. 36, No. 17We consistently observed that NHEJ catalyzed by PC-C in
the presence of IP6 was lower than that obtained with
unfractionated WCE (data not shown), and reasoned
that phosphocellulose fractionation must remove factors
that contribute to the high levels of NHEJ catalyzed by
WCE. To ensure that we were working with all of the
factors necessary for eﬃcient NHEJ in vitro, in the present
study we used an IP6-complementation assay based on
WCE. Ammonium sulphate precipitation (65%) of WCE
was used to generate a fraction (AS65) that contained the
majority of proteins found in WCE and required IP6 for
eﬃcient NHEJ in vitro. We observed that protein levels of
NHEJ factors (Ku70, Ku80, DNA-PKcs, XRCC4 and
ligase IV) were comparable between WCE and the AS65
fraction (Supplementary Figure 1). End joining catalyzed
by the AS65 fraction, as characterized by the formation of
concatamers, was greatly reduced when compared with
end joining catalyzed by WCE (Figure 1B, compare
lanes 2 and 5). Addition of IP6 to the AS65 fraction
restored concatamer formation to levels that recapitulated
WCE-catalyzed end joining (Figure 1B, lanes 5–8). End
joining catalyzed by WCE was unaﬀected by addition of
IP6 (data not shown), suggesting that suﬃcient IP6 for
maximum NHEJ was already present in these extracts.
To conﬁrm that the observed IP6-dependent DNA end
joining was bona ﬁde NHEJ, we treated reactions with the
PI3-kinase inhibitor wortmannin, which inhibits DNA-
PKcs activity (6), or with neutralizing anti-XRCC4 anti-
bodies to assess requirements for DNA-PK and XRCC4,
respectively. As shown in Figure 1B, treatment with either
wortmannin or anti-XRCC4 antibodies inhibited ligation
in WCE and in IP6-complemented AS65. The requirement
for IP6 was speciﬁc, as IS6, which has a negative-charge to
mass ratio similar to that of IP6, could not stimulate end
joining in vitro (Figure 1B). Taken together, these data
demonstrate that the IP6-dependent ligation activity is
classical, DNA-PK-dependent, XRCC4-dependent NHEJ
and shows that IP6 speciﬁcally stimulates NHEJ in vitro.
Time-course experiments showed that both the rate and
extent of end joining by WCE and by the IP6-complemen-
ted AS65 were similar (data not shown). In the absence of
IP6, however, the extent of concatamer formation was
signiﬁcantly reduced relative to similar reactions in the
presence of IP6 (Figure 1C). Control experiments
showed that all of the end joining shown in Figure 1C
was sensitive to neutralizing anti-XRCC4 antibodies and
was therefore bona ﬁde NHEJ (Figure 1D). These data
show that ammonium sulphate precipitation can be used
to generate a crude fraction (AS65) that catalyzes IP6-
dependent NHEJ that is as eﬃcient as WCE and empha-
size the importance of IP6 in NHEJ in vitro.
Identification ofan IP6-binding site in Ku
Previously, we used gel ﬁltration to show that Ku puriﬁed
from HeLa cells was capable of binding IP6 (10). To exam-
ine the IP6-binding properties of Ku in greater detail,
we developed a ﬁlter-binding assay and used competition
analysis to assess the speciﬁcity of
3H-IP6-binding by wild-
type recombinant Ku. To generate the data presented in
Figure 2A, 46.3 nM
3H-IP6 was combined with increasing
amounts of unlabeled IP6 or IS6 before adding Ku to the
binding reactions. Wild-type recombinant Ku selectively
bound IP6 and did not bind IS6 (Figure 2A), the charge-
to-mass analog of IP6 that failed to stimulate NHEJ in the
PC-C (9) and AS65 (Figure 1B) fractions. Because binding
reactions were carried out with 500nMKu, >500nM
unlabeled IP6 was required to reduce bound
3H-IP6 by
50%. Impurities in the only commercially available
source of
3H-IP6 limited the scope of possible experiments
(see Materials and Methods section). Nonetheless, these
data recapitulate the previously observed IP6-binding by
wild-type Ku (10,11) and demonstrate that the available
3H-IP6 can be used to assess speciﬁc IP6 binding.
IP6 is a six-carbon ring that is phosphorylated on all six
carbons (Figure 1A). At physiological pH, IP6 has a high
negative charge-to-mass ratio, which predicts that electro-
static interactions play a large role in Ku IP6 binding. In
support of this prediction, we found that binding of IP6 by
Ku was very sensitive to the ionic strength of the binding
reaction (data not shown). The chemical nature of IP6 and
the importance of charge-based interactions suggested
that an IP6-binding site would be composed of several
positively charged amino acids. We had previously
shown that binding of IP6 by Ku aﬀected the partial pro-
teolysis patterns of both Ku70 and Ku80 subunits but did
not aﬀect DNA binding by Ku (10,11). Based on these
observations, we predicted that the basic amino acids
making up the Ku IP6-binding site would be found on
both subunits of Ku, and that these residues would not
participate in DNA binding.
Through examination of the human Ku crystal struc-
ture (8), we identiﬁed a cluster of basic residues that might
act as an IP6-binding site. This putative IP6-binding site is
composed of lysines and arginines that do not participate
in DNA binding and are located on both the Ku70 and
Ku80 subunits. Multiple sequence alignments show that
these residues are conserved between mammals (Tables 1
and 2), which suggested that these basic amino acids might
play an important part in the biochemistry of Ku. The
putative IP6-binding site is located between the base of
the Ku80N-terminal a/b domain and the Ku70 central
b-barrel domain (Figure 2B and C), which places it on
the side of Ku that faces the continuous DNA strand,
rather than toward the exposed DNA terminus.
To determine if this cluster of conserved, basic amino
acids could act as an IP6-binding site, we mutated groups
of lysines to alanines to produce mutant Ku subunits with
reduced positive charge in the putative IP6-binding site. In
the Ku80 subunit, lysines 238 and 239 (Figure 2D, dark
gray spheres) were mutated to alanines to produce the
double residue mutant Ku80
K238A/K239A, which we will
refer to as 80
DM. Ku80 lysine 233 (Figure 2D, black
sphere), which is less conserved than lysines 238 and 239
but located such that it may contribute to IP6 binding,
was also mutated to alanine to create the triple residue
mutant Ku80
K233A/K238A/K239A, which we will refer to as
80
TM. In the Ku70 subunit, lysines 357 and 358
(Figure 2D, pink spheres) were mutated to alanines to
create the double residue mutant Ku70
K357A/K358A,
which we will refer to as 70
DM.
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Ku80 participate in IP6 binding, we expressed each of
the mutant Ku subunits with its wild-type partner
(Ku70/80
DM, Ku70/80
TM and Ku70
DM/80) to create
single-subunit mutants of Ku. The control protein in
which both subunits were wild-type (Ku70/80) was also
expressed. All proteins described in this work were
expressed by coinfection of insect cells with baculoviruses
expressing individual Ku subunits and puriﬁed as
described in Materials and Methods section. Cell lysis
and immobilized metal aﬃnity chelating chromatography
were carried out in high salt to minimize copuriﬁcation of
IP6. All of the recombinant proteins puriﬁed as heterodi-
mers (Figure 3A and Supplementary Figure 2), which
demonstrated that these mutations had little, if any,
eﬀect on the quaternary structure of the recombinant
Ku proteins.
When the Ku single subunit lysine-to-alanine mutants
were assayed for IP6 binding we found that, for all three of
the single-subunit mutant heterodimers tested, IP6-binding
was reduced relative to binding by wild-type Ku
(Figure 3B). Limitations associated with the
3H-IP6 (see
Materials and Methods section) prevented binding mea-
surements at concentrations >500 nM, making binding
constant measurements imprecise and restricting this anal-
ysis to relative binding by the recombinant Ku proteins.
At 463 nM
3H-IP6, the mutant Ku proteins showed a
spectrum of IP6-binding aﬃnities at 58.5% of wild-type
(Ku70/80
DM), 39.6% (Ku70/80
TM) and 17.4% of wild-
type (Ku70
DM/80), which suggested that lysines in the
IP6-binding site did not participate equally in IP6 binding.
These results show that our mutational analysis has
identiﬁed an IP6-binding site in Ku and that residues
from both Ku70 and Ku80 participate in IP6 binding,
which makes the IP6-binding site of Ku bipartite. This
mutational analysis has also produced mutant proteins
with reduced aﬃnities for IP6.
IP6-binding mutants of Kuare impaired for
participation in NHEJ
To assess the ability of Ku IP6-binding mutants to partici-
pate in NHEJ, we developed an assay system that required
addition of both Ku and IP6 for NHEJ in vitro. Starting
with the AS65 fraction, which required addition of IP6 for
eﬃcient NHEJ, high-salt conditions were used to disrupt
Ku–protein and Ku–DNA interactions and selectively
immunodepleted the abundant Ku protein (12). We con-
ﬁrmed that the Ku-depleted extracts contained no detect-
able levels of Ku70 or Ku80, but that the levels of other
NHEJ factors were unaﬀected (Supplementary Figure 1).
In the presence of IP6, Ku-depleted AS65 had reduced end-
joining activity relative to mock-depleted AS65, which was
consistent with depletion of Ku (Figure 4A and
Supplementary Figure 3). The end joining that was
observed in the Ku-depleted AS65 was not sensitive to
treatment with neutralizing anti-XRCC4 antibodies
(Supplementary Figure 3A). We attribute this Ku-,
XRCC4-independent concatamer formation to DNA
ligases I and III, which had increased access to the DNA
ends in the absence of Ku and were present in the Ku-
depleted AS65 (Supplementary Figure 1). We conclude
that the end joining observed in the Ku-depleted AS65
(Figure 4A, lane 3) does not represent background levels
Table 1. Basic amino acids identiﬁed as candidate mediators of IP6-binding by Ku—Ku70 sequence alignment
Human Mouse Rat Hamster Chicken Xenopus Zebraﬁsh S. pombe S. cerevisiae
K 357 K K K K K K K H
K 358 K N K Q K LPY
K 443 K K K K II II
R 444 R R R R R R R R
K 445 K K K N K TSK
Accession numbers for the Ku70 amino acid sequences—Human, AAH12154; mouse, BAA28874; rat, AAH78718; hamster, AAB46854; chicken,
BAA32018; Xenopus, NP_001082274; zebraﬁsh, ABI54461; S. pombe, O94395; S. cerevisiae, P32807. Multiple sequence alignment was done using
Clustal W (1.83). Amino acids that may participate in IP6 binding by human Ku and the corresponding residues of other species as shown. Basic
amino acids (lysines, K or arginines, R) are in bold. Lysine residues mutated in this study are underlined.
Table 2. Basic amino acids identiﬁed as candidate mediators of IP6-binding by Ku—Ku80 sequence alignment
Human Mouse Rat Hamster Xenopus Zebraﬁsh S. pombe S. cerevisiae Drosophila
R4 4 R R R R RHN D
R 232 R Q R EE GP H
K 233 QQ RRK R S–
K 238 K K K K KTN K
K 239 K K K K RSC V
K 413 K K K K KEI T
K 481 K K K K HNE A
Accession numbers for the Ku80 amino acid sequences—Human, AAH95442; mouse, NP_033559; rat, NP_803154; hamster, 2211394A &
AAC52664; Xenopus, BAA76954; zebraﬁsh, NP_001017360; S. pombe, Q9HGM8; S. cerevisiae, Q04437; D. melanogaster (Drosophila),
AAF63744. Multiple sequence alignment was done using Clustal W (1.83). Amino acids that may participate in IP6 binding by human Ku and
the corresponding residues of other species as shown. Basic amino acids (lysines, K or arginines, R) are in bold. Lysine residues mutated in this study
are underlined.
5718 Nucleic Acids Research, 2008, Vol. 36, No. 17Figure 3. Characterization of single-subunit IP6-binding mutants of Ku. (A) Puriﬁed Ku proteins used in this study. WT, wild-type Ku70/80; 80DM,
Ku70/Ku80
DM; 80TM, Ku70/Ku80
TM; 70DM, Ku70
DM/Ku80. Mutant heterodimers were produced by coexpressing K-to-A mutant subunits with
the corresponding wild-type subunit followed by puriﬁcation as described in Materials and Methods section. A total of 0.5mg total protein was
resolved on 8% SDS–PAGE and silver stained. (B) Single-subunit Ku IP6-binding mutants had decreased IP6 binding relative to wild-type Ku. Filter
binding assays were conducted as described in Materials and Methods section with 500 nM of recombinant Ku (wild-type or IP6-binding mutants)
and
3H-IP6 (as indicated). Values shown represent the mean of at least two independent experiments with each measurement made in triplicate
(N=minimum of 2 and n=minimum of 6). Error bars show standard error. WT, wild-type Ku70/80; 80DM, Ku70/Ku80
DM; 80TM, Ku70/
Ku80
TM; 70DM, Ku70
DM/Ku80.
Figure 4. Single-subunit IP6-binding mutants of Ku are impaired for complementation of end joining in vitro. (A) Top: Ku-depleted AS65 (20mg) was
complemented with 1mMI P 6 and assayed for in vitro NHEJ as described in Materials and Methods section in the absence (lane 3) or presence (lanes
4–7) of recombinant Ku (180nM, wild-type or IP6-binding mutants). End joining observed in the absence of Ku (lane 3) was not sensitive to
neutralizing anti-XRCC4 antibodies (Supplementary Figure 3A) and does not represent background levels of NHEJ. Mock-depleted AS65, anti-Ku
antibodies omitted from immunodepletion. The negative sign indicates no protein. Top panel was assembled from lanes from a single autoradiogram.
Bottom: anti-Ku70 Western blot shows the amount of endogenous Ku70 (lanes 2, 3) or recombinant Ku70 (lanes 4–7) present in the end-joining
reactions (Top). Lane 2 shows the amount of endogenous Ku present in mock-depleted AS65 and lane 3 shows the extent of Ku depletion. Bottom
panel was assembled from lanes from a single western blot. (B) Increasing IP6 increases end joining in reactions complemented by single-subunit
IP6-binding mutants of Ku. Ku-depleted AS65 (20mg) was complemented with 180 nM recombinant Ku (wild-type or IP6-binding mutants) and IP6
(as indicated), assayed for in vitro NHEJ, quantiﬁed as described in Materials and Methods section and normalized to the mean of end joining in the
presence of wild-type Ku at 1mMI P 6. Values shown represent the mean of two independent experiments with each measurement made in duplicate
(N=2 and n=4). (C) Representative FLA-7000 Image Reader images used to generate (B). Figure was assembled from results from a single
experiment.
Nucleic Acids Research, 2008, Vol. 36, No. 17 5719of ligase IV-mediated NHEJ, but rather adventitious con-
catamer formation by ligase I or III.
Using western blot analysis to compare puriﬁed, recom-
binant, wild-type Ku of known concentration with the Ku
in AS65 we determined that Ku was present at  180nM
in the AS65 fraction (data not shown). Addition of 180
nM wild-type recombinant Ku to the Ku-depleted AS65
fraction restored both the Ku protein and IP6-dependent
end joining to levels observed with the mock-depleted con-
trol (Figure 4A and Supplementary Figure 3B).
Complementation with single-subunit Ku IP6-binding
mutants under standard assay conditions (1mMI P 6)
failed to restore NHEJ activity to levels achieved
with wild-type Ku (Figure 4). Ku-complemented, IP6-
dependent end joining was sensitive to treatment with
wortmannin or anti-XRCC4 antibodies (Supplementary
Figure 3B), indicating that complementation with IP6
and recombinant Ku proteins restored bona ﬁde NHEJ
that was dependent upon both DNA-PKcs and XRCC4.
End joining was not observed in Ku-complemented reac-
tions that contained IS6 (data not shown). These data
demonstrate a link between formation of the Ku-IP6 com-
plex and NHEJ in vitro.
Positive correlation between Ku-IP6 bindingand
end-joining activity in vitro
Direct binding studies with
3H-IP6 showed that IP6 bind-
ing by the single-subunit mutant Ku proteins increased
with increasing
3H-IP6 concentration (Figure 3B).
Because the impaired NHEJ observed with the single-sub-
unit Ku IP6-binding mutants (Figure 4) showed a positive
correlation with IP6-binding activity (Figure 3B), we pre-
dicted that the single-subunit mutants should be able to
carry out more eﬃcient NHEJ at higher concentrations of
IP6. As shown in Figure 4, increases in IP6 concentration
resulted in increased NHEJ for all of the recombinant Ku
proteins examined. Notably, at 5mMI P 6, reactions com-
plemented with single-subunit Ku IP6-binding mutants
were indistinguishable from those complemented with
wild-type Ku (Figure 4C, lanes 13–16).
Time-course experiments showed that the rate of con-
catamer formation in reactions complemented with single-
subunit Ku IP6-binding mutants was reduced relative to
that of wild-type Ku (Supplementary Figure 4).
Furthermore, decreases in reaction rate correlated with
relative decreases in IP6-binding (Figure 3B). These data
show striking similarities to the AS65 time course shown
in Figure 1C. Speciﬁcally, end joining in reactions com-
plemented with wild-type Ku and IP6 (Supplementary
Figure 4, top) reached a maximum near 120min, as did
the AS65 fraction in the presence of IP6 (Figure 1C, left).
Reactions complemented with single-subunit IP6-binding
mutant Ku proteins (Supplementary Figure 4) and reac-
tions carried out with AS65 in the absence of IP6
(Figure 1C, right) showed similar levels of end joining
that continued to increase without reaching an apparent
maximum, even after 4h of incubation.
Control reactions showed that, in the absence of IP6,
NHEJ was minimal in reactions complemented with any
of the Ku proteins used in this study (Figure 4C and
Supplementary Figure 4). In the absence of Ku, however,
concatamer formation was driven by factors that were
insensitive to treatment with anti-XRCC4 antibodies
(Supplementary Figure 3A) and was therefore not classical
NHEJ. Concatamer formation that was independent of
Ku, IP6 and XRCC4 (Supplementary Figure 3A) may
represent the in vitro activity associated with the recently
described alternative or nonclassical end-joining pathway
(15–19). We believe that concatamer formation observed
in the absence of Ku did not represent background levels
of ligase IV-catalyzed NHEJ, but represent a separate
ligation mechanism that is normally inhibited in the pres-
ence of Ku.
Taken together, data presented in Figure 4 and
Supplementary Figures 3 and 4 demonstrate that single-
subunit lysine-to-alanine mutants of Ku are not impaired
for participation in NHEJ but required higher concentra-
tions of IP6 to compensate for reductions in IP6 aﬃnity.
Moreover, these data corroborate the observation that
formation of a Ku–IP6 complex is an important part of
the NHEJ reaction.
Kusubunits actsynergistically inIP6binding
Thus far, our data show that Ku heterodimers with muta-
tions in either Ku70 or Ku80 had moderate reductions in
IP6 binding. This suggested that mutation of 2–3 lysines to
alanines within individual subunits of Ku was insuﬃcient
to prevent binding of the highly charged IP6 by the
remaining positively charged residues. Figure 2 shows
that residues from Ku70 and Ku80 may contribute to
the overall positive charge within the bipartite IP6-binding
site of Ku and Figure 3 conﬁrms the role of basic residues
from both Ku70 and Ku80 in IP6 binding. These data
suggest that multiple lysine-to-alanine mutations from
both Ku subunits are necessary to achieve a signiﬁcant
decrease in IP6 binding. To address this possibility, we
coinfected insect cells with viruses that expressed
Ku70
DM and either Ku80
DM or Ku80
TM to produce
recombinant heterodimeric proteins in which both sub-
units carry mutations in the Ku IP6-binding site: combi-
natorial mutants Ku70
DM/80
DM and Ku70
DM/80
TM.
Expression and puriﬁcation of these combinatorial
mutants showed that the mutant subunits formed stable
heterodimers, indicating that the mutations did not signif-
icantly interfere with protein folding (Supplementary
Figure 2B).
When the combinatorial mutants were assayed for IP6
binding, we found that combining lysine-to-alanine muta-
tions in Ku70 with those in Ku80 greatly reduced IP6
binding to 3.78% (Ku70
DM/80
DM) or 1.22% (Ku70
DM/
80
TM) of that observed with wild-type Ku (Figure 5).
While IP6 binding by the combinatorial IP6-binding
mutants was severely diminished, the remaining IP6-bind-
ing activity was measurable and within the conﬁdence
limits of the IP6-binding assay. Therefore, the combina-
torial mutants had signiﬁcantly reduced, but not abol-
ished, IP6-binding activity. The synergistic eﬀects of
combining Ku70
DM with Ku80
DM or Ku80
TM further
support the description of the Ku IP6-binding site as
5720 Nucleic Acids Research, 2008, Vol. 36, No. 17bipartite and demonstrate that we have correctly identiﬁed
the IP6-binding site of Ku.
Combinatorial IP6-binding mutants of Kuare
impaired forparticipation in NHEJ in vitro
To determine if the combinatorial IP6-binding mutants of
Ku were also impaired for participation in NHEJ in vitro,
we complemented the Ku-depleted AS65 fraction with
puriﬁed, recombinant wild-type and combinatorial IP6-
binding mutant Ku proteins (Figure 5B–D). As observed
with the single-subunit IP6-binding mutants, reactions
complemented with Ku70
DM/80
TM showed ineﬃcient
end joining in the absence of IP6 (Figure 5B). Under stan-
dard assay conditions (1mMI P 6), complementation of
Ku-depleted AS65 with Ku70/80
TM or Ku70
DM/80
Figure 5. Combinatorial IP6-binding mutants of Ku are impaired for complementation of end joining in vitro. (A) Combinatorial Ku IP6-binding
mutants had decreased IP6 binding relative to wild-type Ku. Filter binding assays were conducted as described in Materials and Methods section
with 500 nM of recombinant Ku (wild-type or IP6-binding mutants) and
3H-IP6 (as indicated). Values shown represent the mean of at least two
independent experiments with each measurement made in triplicate (N=minimum of 2 and n=minimum of 6). Error bars show standard error.
WT, wild-type Ku70/80; 80DM70DM, Ku70
DM/Ku80
DM; 80TM70DM, Ku70
DM/Ku80
TM.( B) Increasing IP6 does not increase end joining in
reactions complemented by combinatorial IP6-binding mutant Ku. Ku-depleted AS65 (20mg) was complemented with 180 nM recombinant Ku
(wild-type or IP6-binding mutants) and IP6 (as indicated), assayed for in vitro NHEJ, quantiﬁed as described in Materials and Methods section and
normalized to the mean of end joining in the presence of wild-type Ku at 1mMI P 6. Values shown represent the mean of two independent
experiments (N=2 and n=minimum of 3). (C) Representative FLA-7000 Image Reader images used to generate (B). Figure was assembled
from results from a single experiment. (D) Comparison of end joining in reactions complemented with wild-type, single-subunit and combinatorial
IP6-binding mutants of Ku. Reactions were carried out as described for (B). WT, wild-type Ku70/80; 80TM, Ku70/Ku80
TM; 70DM, Ku70
DM/Ku80;
80TM70DM, Ku70
DM/Ku80
TM.
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mentation with Ku70
DM/80
TM did not. When the concen-
tration of IP6 was raised to 10mM, end joining in reactions
complemented with Ku70/80
TM or Ku70
DM/80 was simi-
lar to that observed in reactions complemented with wild-
type Ku, while complementation with Ku70
DM/80
TM
resulted in very little end joining. These data show that
the combinatorial mutant Ku70
DM/80
TM, which was
severely impaired for IP6 binding, was also impaired for
participation in NHEJ.
Ku70
DM/80
TM retained only 1.22% of wild-type IP6-
binding activity and was severely impaired for participa-
tion in NHEJ, while Ku70
DM/80
DM was less impaired for
NHEJ and retained 3.78% of wild-type IP6 binding.
Figure 5C and D shows that the eﬃciency of end joining
in reactions complemented with both combinatorial IP6-
binding mutants of Ku reached a maximum at 1mMI P 6
and did not change with increasing IP6 concentration. The
IP6-dependent end joining observed with the combinato-
rial mutants may be due to the low, but measurable, IP6-
bindng activity observed with Ku70
DM/80
DM and
Ku70
DM/80
TM. Alternately, while Ku depletion of the
AS65 fraction used in the complementation experiments
shown in Figure 5 was conﬁrmed by western blot analysis,
we cannot rule out the possibility that the IP6-dependent
end joining observed in Figure 5 may be due to residual
endogenous Ku that was below the limit of western blot
detection.
We found that variations in the preparation of the Ku-
depleted AS65 fraction could lead to diﬀerences in the
amount of end joining observed in Ku-complemented
reactions. To directly compare the ability of combinatorial
and single-subunit IP6-binding mutants of Ku, we carried
out the complementation reactions shown in Figure 5D.
As previously observed, end joining in reactions comple-
mented with wild-type recombinant Ku (WT) appeared to
reach a maximum at 1mMI P 6, with no further increase in
NHEJ product formation observed at 10mMI P 6.A t1mM
IP6, end joining in reactions complemented with the
single-subunit IP6-binding mutants of Ku, Ku70/80
TM
(80TM) and Ku70
DM/80 (70DM), was reduced relative
to reactions complemented with wild-type Ku. End join-
ing in single-subunit IP6-binding mutant complemented
reactions increased with increasing IP6 concentration
and at 10mM were indistinguishable from reactions com-
plemented with wild-type Ku. In contrast, reactions com-
plemented with the combinatorial mutant Ku70
DM/80
TM
(70DM80TM), which retained only 1.22% of wild-type
IP6-binding activity, produced very little end joining pro-
duct under all IP6 concentrations examined. The direct
comparison presented in Figure 5D reinforces the correla-
tion between Ku IP6 binding and NHEJ in vitro and bipar-
tite nature of the Ku IP6-binding site.
Separationof DNA-PK activation andIP6-binding
propertiesof Ku
With the exception of IP6 binding, the established func-
tions of Ku in NHEJ are conﬁned to its role in DNA-PK
where Ku binds dsDNA ends (20,21) and contacts DNA-
PKcs through the C-terminal domain of Ku80 to activate
DNA-PKcs (22). It has been shown that binding of IP6 by
Ku does not aﬀect the ability of Ku to bind DNA or to
participate in DNA-PK assembly and that DNA-PK can
assemble on DNA in a complex that incorporates IP6
(10,11). Consistent with these reports, we show here that
the IP6-binding site of Ku is located away from sites of
DNA and DNA-PKcs binding. Based on these ﬁndings,
we predicted that the IP6-binding mutants of Ku would
be separation-of-function mutants that retain wild-
type DNA-binding activity and the ability to activate
DNA-PKcs.
First, we compared DNA binding by wild-type recom-
binant Ku, the single-subunit mutants Ku70/80
TM and
Ku70
DM/80 and the combinatorial mutants Ku70
DM/
80
DM and Ku70
DM/80
TM. The DNA used in this study,
originally described by Walker et al. (8), uses a short piece
of duplex DNA that can accommodate only one Ku pro-
tein. The termini of the synthetic duplex DNA permit
directional loading of Ku from only one exposed end.
Loading from the second terminus is prevented by the
presence of an unpaired region, which can form a ham-
merhead structure (8). We used EMSA to assess DNA
binding by wild-type and IP6-binding mutants of Ku. A
representative EMSA (Figure 6A) and the cumulative
results of three experiments (Figure 6B) show that binding
of a single Ku protein to DNA is comparable for all of the
Ku proteins tested.
We also compared the DNA-end binding properties of
the wild-type and IP6-binding mutant Ku proteins by
EMSA using a 48-bp duplex, which is large enough to
permit loading of two Ku heterodimers. As shown by
the representative EMSA data presented in
Supplementary Figure 5, the dsDNA-binding activities
of the three single subunit and the two combinatorial
mutants IP6-binding mutants were comparable to that of
wild-type Ku. Small diﬀerences (1–5%) in DNA binding
were observed between experiments, which we attribute to
experimental variation. While cooperative binding by Ku
has reported (20), we found that mutation of the Ku IP6-
binding site did not change the ability of Ku to form a two
Ku:one DNA complex (Supplementary Figure 5).
Additionally, the ability of Ku to speciﬁcally bind to
exposed dsDNA termini was unaﬀected by mutation of
the IP6-binding site as neither single-stranded
(Supplementary Figure 6) nor supercoiled circular DNA
(data not shown) could compete for binding by recombi-
nant wild-type or IP6-binding mutant Ku proteins.
Having determined that the DNA-binding properties of
Ku were unaﬀected by mutation of the IP6-binding site,
we went on to assess the ability of Ku IP6-binding mutants
to stimulate DNA-PKcs by comparing the ability of the
wild-type and mutant Ku proteins to participate in phos-
phorylation of a p53 peptide substrate. DNA-PKcs is an
active protein kinase in the absence of Ku (23,24). In this
assay system, however, we did not observe signiﬁcant
phosphorylation of the p53 peptide substrate in reactions
lacking Ku (Figure 6C and D). We saw no diﬀerence
between the ability of recombinant wild-type Ku and the
moderately impaired single-subunit IP6-binding mutants
of Ku to stimulate phosphorylation of a peptide substrate
by DNA-PKcs (Figure 6C). Similarly, no diﬀerence was
5722 Nucleic Acids Research, 2008, Vol. 36, No. 17observed between the ability of wild-type Ku and the more
severely impaired combinatorial IP6-binding mutants to
stimulate DNA-PKcs (Figure 6D). We attribute the diﬀer-
ences in DNA-PK activity between experiments
(Figure 6C and D) to experimental variation.
Taken together, the data presented in Figure 6 show
that IP6-binding mutants of Ku with varying degrees of
reduced aﬃnity for IP6 are not altered for DNA-end bind-
ing or for DNA-PKcs stimulation. Importantly, these data
demonstrate that the IP6-binding and NHEJ complemen-
tation experiments shown in Figures 3–5 were carried out
with functionally equivalent amounts of recombinant Ku
proteins. All of the IP6-binding mutants of Ku represent
separation-of-function mutants that highlight the role of
Ku as an IP6-binding protein, apart from its role in DNA-
PK, in mammalian NHEJ.
DISCUSSION
We previously reported that Ku binds IP6, which can act
as a stimulator of NHEJ in vitro, and the formation of a
Ku–IP6 complex alters the protease accessibility of both
Ku70 and Ku80 subunits (9,10). These results suggest that
IP6 binding may illicit changes in the structure of both Ku
subunits. Here, we report the identiﬁcation of a bipartite
IP6-binding site in Ku, which is comprised of residues
from both Ku80 and Ku70 subunits and is located away
from both the DNA-binding and DNA-PKcs-binding
sites of Ku (8). Multiple sequence alignment showed
that the IP6-binding site of Ku, like the IP6-binding site
in the RNA editing enzyme ADAR2 (25), carries an over-
all positive charge and contains basic residues that are
invariant among mammals. Distribution of positively
charged amino acids that coordinate binding of IP6
between Ku70 and Ku80 make the IP6-binding site of
Ku bipartite, as is the DNA-binding site (Figure 2).
The mutational analysis presented here conﬁrms the role
of these basic residues in IP6 binding and we have
observed that combining lysine-to-alanine mutations in
Ku70 with similar changes in Ku80 has a synergistic
eﬀect on reducing IP6 binding. These basic amino acids
do not appear to be found in the yeasts Saccharomyces
cerevisiae or Schizosaccharomyces pombe (Tables 1 and 2),
which is in keeping with the observation that yKu70/80
failed to interact with IP6 (10). Like DNA-PKcs, which
has no homolog in yeast, the binding of IP6 by Ku and
modulation of NHEJ by IP6 are apparently unique to
mammalian NHEJ.
Figure 6. Separation of IP6-binding- and DNA-PK-related functions of Ku. (A) dsDNA binding by IP6-binding mutants of Ku. EMSA carried out
with 5 nM of
32P-end labeled dsDNA and recombinant Ku (as indicated) at 0, 2.5, 5 and 10 nM. Complexes were resolved on 5% native PAGE.
Free dsDNA and dsDNA bound by 1 Ku protein as indicated. (B) DNA binding by wild-type and IP6-binding mutants of Ku. EMSA was carried
out as described for (A) with recombinant Ku proteins as indicated and quantiﬁed as described in Materials and Methods section and expressed as
percentage of protein-bound DNA. Values shown represent the mean of three independent experiments. (C) Mutation of the IP6-binding site did not
aﬀect activation of DNA-PKcs—analysis of single-subunit IP6-binding mutants. DNA-PK assays were carried out as described using Ku-free DNA-
PKcs (0.463 pmol) puriﬁed from HeLa cells and 0, 0.25, 0.6, 0.9 or 1.5 pmol recombinant Ku (wild-type or IP6-binding mutants) and 10mg/ml DNA.
(D) Mutation of the IP6-binding site did not aﬀect activation of DNA-PKcs—analysis of combinatorial IP6-binding mutants. DNA-PK assays were
carried out as described for (B) with recombinant Ku proteins as indicated. Values shown for DNA-PK assays represent the mean of two
independent experiments with each measurement made in triplicate (N=2 and n=6). Error bars show standard error. WT, wild-type Ku70/80;
80DM, Ku70/Ku80
DM; 80TM, Ku70/Ku80
TM; 70DM, Ku70
DM/Ku80; 80DM70DM, Ku70
DM/Ku80
DM; 80TM70DM, Ku70
DM/Ku80
TM.
Nucleic Acids Research, 2008, Vol. 36, No. 17 5723Separation-of-function mutants of Ku generated in this
study conﬁrm the functionality of the bipartite IP6-bind-
ing site identiﬁed in human Ku and highlight the impor-
tance of a Ku–IP6 complex in mammalian NHEJ. These
mutants represent a spectrum of reduced aﬃnities for IP6,
while retaining the ability to heterodimerize, bind dsDNA
and stimulate DNA-PK for phosphorylation of a com-
monly used p53 peptide substrate. Most signiﬁcantly,
these Ku IP6-binding mutants are impaired for their abil-
ity to participate in NHEJ in vitro. We observed a correla-
tion between IP6 aﬃnity and NHEJ activity, and found
that single-subunit IP6-binding mutants of Ku could eﬀec-
tively stimulate NHEJ when IP6 levels were appropriately
increased. These data show that the single-subunit IP6-
binding mutants of Ku are not absolutely deﬁcient for
participation in NHEJ, but simply impaired for IP6 bind-
ing, which is necessary for eﬃcient NHEJ in vitro.
Ku interacts with DNA and DNA-PKcs using nonover-
lapping binding sites that permit formation of the active
DNA-PK. We show here that the IP6-binding site of Ku is
located away from the sites of both DNA binding and
DNA-PKcs binding, which is in structural agreement
with formation of a DNA/DNA-PKcs/Ku–IP6 complex.
We had previously observed that direct addition of IP6 to
DNA-PK reactions had no eﬀect on protein kinase activ-
ity, the requirement for DNA or inhibition by wortman-
nin (L.A.H. and West, unpublished observation).
Additionally, a Ku heterodimer composed of a wild
type, full-length Ku70 and a C-terminally truncated
Ku80, which lacked the DNA-PKcs binding site of Ku,
bound IP6 as well, if not better, than wild-type, full-length
Ku70/80 (10). In light of this history, it is not surprising
that stimulation of DNA-PK by wild-type Ku and IP6-
binding mutants of Ku are comparable. Taken together,
these ﬁndings demonstrate that binding of IP6 by Ku does
not aﬀect DNA binding by Ku (11), assembly of DNA-PK
(10,11) or DNA-PK activity.
Genetic analysis of mammalian V(D)J recombination
suggests that the role of Ku is not restricted to its partici-
pation in DNA-PK. As referenced earlier, Ku deﬁciencies
do not phenocopy a DNA-PKcs deﬁciency. Speciﬁcally,
Ku70- and Ku80-deﬁcient mice fail to produce signal and
coding joints, while in DNA-PKcs-deﬁcient animals signal
joint formation is retained (6,7). Our ﬁndings indicate that
binding of IP6 and stimulation of DNA-PK are indepen-
dent functions of Ku. Furthermore, these data imply that
Ku plays a DNA-PK-independent role in mammalian
NHEJ that is regulated by binding of IP6.
Inositol polyphosphatesas regulators ofnuclear processes
The inositol phosphates (InsPs) have been shown to reg-
ulate a number of important nuclear functions, including
ATP-dependent chromatin remodeling (26), telomere
length maintenance (27,28), adenosine deamination in
RNA editing (25) and mRNA export (29,30). InsPs can
directly participate in these pathways, as typiﬁed by the
RNA editing adenosine deaminase ADAR2 where binding
of IP6 by ADAR2 is required for ADAR2 catalytic activ-
ity (25). There is also evidence for indirect participation of
InsPs, as is the case with stimulation of Dpn5 ATPase
activity by the Gle1–IP6 complex in mRNA export (30).
Given that Ku possesses no known enzymatic activities, it
is most likely that IP6 acts indirectly to stimulate NHEJ by
modulating interactions between Ku and other nuclear
factors.
StudiesofInsPmetabolismhavefoundthatInsPhomeo-
stasis is highly regulated and that intracellular concentra-
tions of IP6, reported to be in the low micromolar range
in mammalian cells, are relatively stable (31). Given these
observations, how can a molecule like IP6 play a regula-
tory role in such a wide variety of nuclear processes? The
current hypothesis suggests that the InsPs, like Ca
2+,
may exist in subcellular pools that can be independently
regulated (32). There is evidence that InsP metabolism,
and therefore the abundance of speciﬁc InsP species, can
be modulated by G protein activation (31), which could
certainly link the InsPs to the cell signaling network. The
recent identiﬁcation of IP6 in the crystal structure of the
Arabidopsis TIR1 ubiquitin ligase, which participates in
the regulation of plant growth through auxin hormone
signaling, highlights the connection between signaling
and InsP metabolism (33).
Possible roles forIP6in NHEJ
While the role of the Ku–IP6 complex in NHEJ remains
elusive, ﬁndings presented here suggest three possible
mechanisms for indirect regulation of NHEJ by IP6.
First, recent publications have shown that multiple low-
aﬃnity protein–protein interactions exist between the
DNA-PK and XRCC4/ligase IV/XLF complexes and
that these apparently weak or transient interactions are
stabilized in the presence of DNA. In particular, Ku70
has been shown to make direct contact with ligase IV
and with XRCC4 (34–36). It is worth noting that the
experiments that deﬁned these interactions between
NHEJ factors were carried out in cell-free extracts,
which presumably contain IP6 (34). These ﬁndings suggest
the hypothesis that binding of IP6 by Ku might inﬂu-
ence the stability of protein–protein interactions that con-
nect the NHEJ apparatus, which results in the observed
stimulation of NHEJ. We believe this to be the most likely
mechanism of IP6 stimulation of mammalian NHEJ and
we are currently investigating the eﬀects of IP6 on the
stability of Ku-XRCC4/ligase IV/XLF interactions.
Second, although we show that formation of a Ku–IP6
complex does not aﬀect any aspect of DNA-PK phosphor-
ylation of a p53 peptide substrate, we cannot rule out the
possibility that binding of IP6 by Ku could aﬀect substrate
selection by DNA-PK, which may inﬂuence NHEJ.
Published work on the role of DNA-PK autophosphory-
lation in NHEJ (37,38) make modulation of DNA-PK
substrate selection a plausible, if unlikely, mechanism for
stimulation of NHEJ by IP6.
Finally, the IP6-binding site of Ku is located on the
surface of Ku that faces the continuous DNA strand (8),
which raises the possibility that IP6 may regulate interac-
tions between Ku and DNA-binding factors that do not
act at the exposed DNA end. Previous ﬁndings have
shown that nucleosome assembly and linker histone H1
binding inhibits NHEJ in vitro (39), and that Ku is capable
5724 Nucleic Acids Research, 2008, Vol. 36, No. 17of displacing assembled nucleosomes and histone H1 (40).
Binding of IP6 to the side of Ku that faces the continuing
DNA strand may aﬀect interactions between Ku and
DNA-binding proteins to increase NHEJ eﬃciency by
stimulating eviction of bound proteins from the region
of the DSB.
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